Almost every pitch deck about infection control in healthcare cites the same statistic. Healthcare-associated infections cost the US system about $28 billion per year. The number is real and it comes from peer-reviewed sources. But the number by itself doesn't tell you where the money is going or what a SNF administrator can actually do about it.
Here's the breakdown the way I think about it.
About $10 billion of that total is direct hospital costs per episode. That's the part that makes sense to everyone. An infected patient requires extra care, extra antibiotics, extra isolation, extra staff time, longer length of stay.
A larger share of the total is downstream costs. Unplanned readmissions when a resident leaves the hospital and gets re-infected within 30 days. Extended nursing home stays when the same resident can't go home on schedule. Antibiotic resistance driven by repeated broad-spectrum treatment. Mortality-adjusted productivity loss for residents who never recover their pre-infection baseline.
For a skilled nursing facility specifically, the number that actually matters more than the $28B headline is the CMS readmission penalty. CMS tracks 30-day all-cause readmission rates for Medicare beneficiaries discharged from a SNF, and facilities whose rate exceeds a national benchmark get a percentage clipped off every future Medicare payment.
A single unplanned readmission from a missed infection can erase the margin on that resident for a full quarter. A pattern of missed infections can erase the facility's Medicare margin for a year.
That's the economic mechanism that makes the $28B figure personal for any SNF administrator. It's not an abstract societal cost borne by everyone. It's a specific line item that shows up on their monthly financial package as a negative adjustment to Medicare reimbursement.
And the driver of missed infections is almost always detection latency. Not missing the fact that something is wrong, nurses and CNAs are very good at noticing that something is wrong, but missing the window to act on it before it becomes something bigger.
I'm not going to claim that VynScan fixes this overnight. The clinical workflow, the culture of a facility, the staffing levels, and the relationship between the DON and the medical director all matter as much as any hardware we ship. What I will claim is that if you believe a big chunk of the $28B is downstream of the time between symptom and action, then the intervention that actually matters is whatever shortens that time. That's what VynScan does, and it's the only thing it tries to do.
One more note for anyone who wants to verify the $28B figure themselves. The canonical source is a CDC-funded meta-analysis, and there are newer analyses from the Agency for Healthcare Research and Quality that reach similar numbers. The top-line figure is stable across sources. What differs is the cost allocation between acute care, post-acute care, and long-term care. For SNF-specific analysis, the AHRQ work is more granular and more useful than the CDC top-line number.
If you're a medical director or a SNF administrator who has ever sat in a meeting where your team tried to explain away a readmission, email me. I want to hear about it.